MSDC-0602
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MSDC-0602, covering 2013-12-20 to 2013-12-20. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients [Phase 2]